Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Helium One secures first helium sales deal with major US industrial gases firm, shares jump 11%.

Market News
04 Jun 2026
Proactive Investors - Finance
View Source
Bullish
pluang ai news

Helium One Global Ltd announced that its 50%-owned Galactica Project has secured its first formal helium offtake agreement with a large US industrial gases company. The three-month deal covers helium produced at the Pinon Canyon Plant until August 31, 2026, with pricing fixed and aligned with the US helium spot market. The buyer is a publicly listed US firm with a multi-billion-dollar market cap and strong credit rating. This agreement provides a commercial bridge from early production to longer-term sales, supporting ongoing plant commissioning and optimization. Blue Star Helium, the operator, is also negotiating further commercial deals for co-produced CO2.

More News

Stablecoin duopoly of USDT and USDC faces rising competition from banks, fintechs, and new issuers.

Stablecoin duopoly of USDT and USDC faces rising competition from banks, fintechs, and new issuers.

Rob Hadick of Dragonfly predicts the stablecoin market will evolve beyond the current USDT and USDC dominance due to increasing competition from banks, fintech companies, and new crypto issuers. This competition will focus on payments, compliance, an...

Market News
Neutral
4 hours ago
Philippines bans privacy coins on licensed crypto platforms, tightening listing rules.

Philippines bans privacy coins on licensed crypto platforms, tightening listing rules.

The Bangko Sentral ng Pilipinas (BSP) has issued a memorandum banning licensed virtual asset service providers (VASPs) from listing privacy-focused tokens that obscure transaction details. This move aligns with global anti-money laundering standards ...

Market News
Bearish
4 hours ago
Legend Biotech's LB2501 shows 100% response in Phase 1 trial for relapsed B-cell lymphoma with good safety.

Legend Biotech's LB2501 shows 100% response in Phase 1 trial for relapsed B-cell lymphoma with good safety.

Legend Biotech announced that its investigational CAR-T therapy LB2501 achieved a 100% objective response rate and 83.3% complete response rate at the higher dose in a Phase 1 trial for relapsed or refractory B-cell non-Hodgkin lymphoma. The single i...

Company Fundamentals
Bullish
4 hours ago
PYTH rebounds 14% from all-time low amid rising demand and staking, hinting at a possible sustained recovery.

PYTH rebounds 14% from all-time low amid rising demand and staking, hinting at a possible sustained recovery.

PYTH Network's price dropped to a record low of around $0.04 before bouncing back 14%, suggesting renewed investor interest after a broad market selloff. Despite facing a major supply zone that could limit gains, rising staking values, increased trad...

Technical Signals
Bullish
4 hours ago
Notcoin jumps 25% amid rising retail interest despite bearish bets in crypto derivatives.

Notcoin jumps 25% amid rising retail interest despite bearish bets in crypto derivatives.

Notcoin (NOT), a cryptocurrency linked to Telegram, surged 25% driven by increased retail interest and rising Google search activity. Despite this price rise, derivatives market data shows traders are heavily betting against it, with open interest hi...

Technical Signals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App